Clinical Trials Browser

Has results × Head and Neck Neoplasms × Dasatinib × Clear all

NCT00882583 2019-01-09

Dasatinib

Phase 1 Terminated

22 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms